Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors
==================================================================================================================================================================================================================================

* Kohei Shitara
* Taroh Satoh
* Satoru Iwasa
* Kensei Yamaguchi
* Kei Muro
* Yoshito Komatsu
* Tomohiro Nishina
* Taito Esaki
* Jun Hasegawa
* Yasuyuki Kakurai
* Emi Kamiyama
* Tomoko Nakata
* Kota Nakamura
* Hayato Sakaki
* Ichinosuke Hyodo